Semaglutide 2.4 mg/wk for weight loss in patients with severe obesity and with or without a history of bariatric surgery

JB Bonnet, S Tournayre, J Anitcheou, M Faivre… - …, 2024 - Wiley Online Library
Objective This retrospective cohort study aimed to assess the effectiveness of semaglutide
2.4 mg in patients with severe obesity (BMI≥ 40 kg/m2) who had previously undergone …
被引用次数：8 相关文章
[PDF] tb2.health

[PDF][PDF] Semaglutide 2.4 mg/wk for weight loss in patients with severe obesity and with or without a history of bariatric surgery

JB Bonnet, S Tournayre, J Anitcheou, M Faivre… - 2023 - research.tb2.health
Objective: This retrospective cohort study aimed to assess the effectiveness of semaglutide
2.4 mg in patients with severe obesity (BMI≥ 40 kg/m2) who had previously undergone …

Semaglutide 2.4 mg/wk for weight loss in patients with severe obesity and with or without a history of bariatric surgery

JB Bonnet, S Tournayre, J Anitcheou… - … (Silver Spring, Md …, 2024 - pubmed.ncbi.nlm.nih.gov
Objective This retrospective cohort study aimed to assess the effectiveness of semaglutide
2.4 mg in patients with severe obesity (BMI≥ 40 kg/m 2) who had previously undergone …

Semaglutide 2.4 mg/wk for weight loss in patients with severe obesity and with or without a history of bariatric surgery.

JB Bonnet, S Tournayre, J Anitcheou… - Obesity (Silver Spring …, 2023 - europepmc.org
Objective This retrospective cohort study aimed to assess the effectiveness of semaglutide
2.4 mg in patients with severe obesity (BMI≥ 40 kg/m 2) who had previously undergone …
[PDF] sochob.cl

[PDF][PDF] Semaglutide 2.4 mg/wk for weight loss in patients with severe obesity and with or without a history of bariatric surgery

JB Bonnet, S Tournayre, J Anitcheou, M Faivre… - 2023 - sochob.cl
Objective: This retrospective cohort study aimed to assess the effectiveness of semaglutide
2.4 mg in patients with severe obesity (BMI≥ 40 kg/m2) who had previously undergone …

Semaglutide 2.4 mg/wk for weight loss in patients with severe obesity and with or without a history of bariatric surgery

J Bonnet, S Tournayre, J Anitcheou, M Faivre… - Obesity, 2023 - hal.science
Objective: This retrospective cohort study aimed to assess the effectiveness of semaglutide
2.4 mg in patients with severe obesity (BMI≥ 40 kg/m 2) who had previously undergone …

Semaglutide 2.4 mg/wk for weight loss in patients with severe obesity and with or without a history of bariatric surgery

J Bonnet, S Tournayre, J Anitcheou, M Faivre… - Obesity, 2024 - cnrs.hal.science
Objective: This retrospective cohort study aimed to assess the effectiveness of semaglutide
2.4 mg in patients with severe obesity (BMI≥ 40 kg/m 2) who had previously undergone …
[PDF] hal.science

[PDF][PDF] Semaglutide 2.4 mg/wk for weight loss in patients with severe obesity and with or without a history of bariatric surgery

J Bonnet, S Tournayre, J Anitcheou, M Faivre… - hal.science
Semaglutide 2.4 mg/wk for weight loss in patients with severe obesity and with or without a
history of bariatric surgery Page 1 HAL Id: hal-04273036 https://hal.science/hal-04273036 …